Skip to main content
Premium Trial:

Request an Annual Quote

Grants that Weren t

Premium

Genome Technology regularly peruses lists of recently funded grant proposals. Some proposals strike us as, shall we say, curious applications of science — which got us wondering about the proposals that are passed over. Here are a few examples of grant proposals that definitely wouldn’t make it through the funding triage.

 

Functional Genomics of Athlete’s Foot: How to Increase Activity, Robustness in Fungus

 

BAM! vs WHAM!: The Comparative Genomics of Emeril and George Michael

 

Using Serum and Proteomic Biomarkers to Identify Specimen Attractiveness in Humans

 

Training Grant in Computational Elmo Genomics

 

Block the Message: Using siRNAs to Inhibit Rude, Inadvertently Sent E-mails

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.